Wall Street is positive on AcelRx Pharmaceuticals Inc (ACRX). On average, analysts give ACRX a Buy rating. The average price target is $80, which means analysts expect the stock to add by 3037.25% over the next twelve months. That average ranking earns ACRX an Analyst Rating of 35, which is better than 35% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating ACRX a Buy today. Find out what this means to you and get the rest of the rankings on ACRX!